Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/102459
Title: Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants
Author: Gomes, Cláudia
Martínez-Puchol, Sandra
Ruiz-Roldan, Lidia
Pons, Maria J.
Valle Mendoza, Juana del
Ruiz, Joaquim
Keywords: Malalties bacterianes
Medicaments antibacterians
Antibiòtics
Bacterial diseases
Antibacterial agents
Antibiotics
Issue Date: 26-Sep-2016
Publisher: Springer Nature
Abstract: The objective was to develop and characterise in vitro Bartonella bacilliformis antibiotic resistant mutants. Three B. bacilliformis strains were plated 35 or 40 times with azithromycin, chloramphenicol, ciprofloxacin or rifampicin discs. Resistance-stability was assessed performing 5 serial passages without antibiotic pressure. MICs were determined with/without Phe-Arg-beta-Napthylamide and artesunate. Target alterations were screened in the 23S rRNA, rplD, rplV, gyrA, gyrB, parC, parE and rpoB genes. Chloramphenicol and ciprofloxacin resistance were the most difficult and easiest (>37.3 and 10.6 passages) to be selected, respectively. All mutants but one selected with chloramphenicol achieved high resistance levels. All rifampicin, one azithromycin and one ciprofloxacin mutants did not totally revert when cultured without antibiotic pressure. Azithromycin resistance was related to L4 substitutions Gln-66 --> Lys or Gly-70 --> Arg; L4 deletion Delta62-65 (Lys-Met-Tyr-Lys) or L22 insertion 83::Val-Ser-Glu-Ala-His-Val-Gly-Lys-Ser; in two chloramphenicol-resistant mutants the 23S rRNA mutation G2372A was detected. GyrA Ala-91 --> Val and Asp-95 --> Gly and GyrB Glu474 --> Lys were detected in ciprofloxacin-resistant mutants. RpoB substitutions Gln-527 --> Arg, His-540 --> Tyr and Ser-545 --> Phe plus Ser-588 --> Tyr were detected in rifampicin-resistant mutants. In 5 mutants the effect of efflux pumps on resistance was observed. Antibiotic resistance was mainly related to target mutations and overexpression of efflux pumps, which might underlie microbiological failures during treatments.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1038/srep33584
It is part of: Scientific Reports, 2016, vol. 6, num. 33584
Related resource: http://dx.doi.org/10.1038/srep33584
URI: http://hdl.handle.net/2445/102459
ISSN: 2045-2322
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
gomes2016_2257.pdf538.92 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons